Miss Charlesworth, who is leading the appeal to help find a match, said her father "means absolutely everything to me". The ...

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

A man called Dan has been documenting his blood cancer journey online. He recently explained there are three common symptoms ...

A cancer survivor has unveiled a pioneering device in the UK, designed to help individuals detect breast abnormalities from ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Steve Pruisner walked 110 miles, step by step during his on the adult stem cell transplant unit at University of Iowa Health ...

The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...

A man has gone viral on TikTok after sharing the three symptoms he experienced before being diagnosed with blood cancer – now he's urging everyone to spot them before it's too late ...

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

Panel B shows the patient at the initial T-cell lymphoma (TCL ... MRD minimal residual disease; and SCT stem-cell transplantation. The patient had elevated levels of serum cytokines after infusion ...